CD14-positive hepatic monocytes/macrophages increase in hereditary hemochromatosis

Liver International

Volumn 24, Issue 5, 2004, Pages 446-451

  Leicester, Katherine L ^a,b   Olynyk, John K ^a,c   Brunt, Elizabeth M ^b   Britton, Robert S ^b   Bacon, Bruce R ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FREMANTLE HOSPITAL   (Australia)

Author keywords

CD14; CD68; Fibrosis; Hepatic stellate cell; Kupffer cell; Liver

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD14 ANTIGEN; CD68 ANTIGEN; COLLAGEN; ENDOTOXIN; BIOLOGICAL MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; FIBROGENESIS; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IRON OVERLOAD; KUPFFER CELL; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MACROPHAGE; MALE; MONOCYTE; MYOFIBROBLAST; STELLATE CELL; CELL COUNT; ENZYME IMMUNOASSAY; GENETICS; IMMUNOLOGY; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; CELL COUNT; HEMOCHROMATOSIS; HUMANS; IMMUNOENZYME TECHNIQUES; KUPFFER CELLS; LIVER; LIVER CIRRHOSIS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES;

EID: 16644375655     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0943.x     Document Type: Article

References (39)

1. Olynyk J K, et al. A population-based study of the clinical expression of the hemochromatosis gene. New Eng J Med 1999; 341(10): 718-24.
2. Harrison S A, Bacon B R. Hereditary hemochromatosis: update for 2003. J Hepatol 2003; 38(Suppl. 1): S14-23.
3. Feder J N, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13(4): 399-408.
4. Bacon B R, Tavill A S. Hemochromatosis and the iron overload syndromes. In: Zakim D, Boyer T D, eds. Hepatology. A Textbook of Liver Disease, 3rd edn. Saunders: Philadelphia, 1996; 1439-72.
5. Hui AY, Friedman S L. Molecular basis of hepatic fibrosis. Expert Rev Mol Med 2003; 14: 1-23.
6. Gabele E, Brenner D A, Rippe R A. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 2003; 8: D69-77.
7. Searle J, et al. Iron storage disease. In: MacSween R N M, et al. eds. Pathology of the Liver. New York: Churchill Livingstone, 1994; 219-41.
8. Deugnier Y M, et al. Liver pathology in genetic hemochromatosis: a review of 135 homo.zygous cases and their bioclinical correlations. Gastroenterology 1992; 102(6): 2050-9.
9. Stal P. Iron as a hepatotoxin. Digest Dis 1995; 13(4): 205-22.
10. Maher J J. Interactions between hepatic stellate cells and the immune system. Semin Liv Dis 2001; 21(3): 417-26.
11. Scherberich J E. Proinflammatory blood monocytes: main effector and target cells in systemic and renal disease; background and therapeutic implications. Int J Clin Pharmacol Ther 2003; 41(10): 459-64.
12. Reeves H L, Friedman S L. Activation of hepatic stellate cells: a key issue in liver fibrosis. Front Biosci 2002; 7: D808-26.
13. Su G L, et al. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. Am J Physiol 2002; 283(3): G640-5.
14. Olynyk J K, et al. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. Gastroenterology 1994; 106(3): 674-7.
15. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105(1): 274-8.
16. Bridle K R, et al. Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. J Hepatol 2003; 38(4): 426-33.
17. Mathew J, et al. Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. Histopathology 1994; 25(1): 65-70.
18. Ferrero E, et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90(6): 2380-4.
19. Morrison D C, et al. Endotoxin receptors on mammalian cells. Immunobiology 1993; 187(3-5): 212-26.
20. Watson RW, Redmond H P, Bouchier-Hayes D. Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses. J Leuko Biol 1994; 56(1): 95-103.
21. Da Silva Correia J, et al. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001; 276(24): 21129-35.
22. Su G L. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol 2002; 283(2): G256-65.
23. Haziot A, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4(4): 407-14.
24. Liu S, et al. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect Immun 1998; 66(11): 5089-98.
25. Zhang X, et al. Effects of lipopolysaccharide stimulated Kupffer cells on activation of rat hepatic stellate cells. World J Gastroenterol 2004; 10(4): 610-3.
26. Gressner A M. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 1995; 22 (2 Suppl.): 28-36.
27. Stal P, et al. Kupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosis. Hepatology 1995; 21(5): 1308-16.
28. Ikejima K, et al. Pronase destroys the lipopolysaccharide receptor CD14 on Kupffer cells. Am J Physiol 1999; 276(3): G591-8.
29. Tracy T F Jr., Fox E S. CD14-lipopolysaccharide receptor activity in hepatic macrophages after cholestatic liver injury. Surgery 1995; 118(2): 371-7.
30. Bellezzo J M, et al. LPS-mediated NF-κB activation in rat Kupffer cells can be induced independently of CD14. Am J Physiol 1996; 270(6): G956-61.
31. Lichtman S N, Wang J, Lemasters J J. LPS receptor CD14 participates in release of TNF-α in RAW 264.7 and peritoneal cells but not in Kupffer cells. Am J Physiol 1998; 275(1): G39-46.
32. Adams P C, et al. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25(1): 162-6.
33. Ramm G A, et al. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997; 26(3): 584-92.
34. Brunt E M, Fazel A, Brown K E. Lack of zonal association between alpha-smooth muscle actin, CD34 and fibrosis in a variety of liver diseases. Hepatology 1999; 30: 554A.
35. Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J Hepatol 1998; 28: 8-13.
36. Ramm G A, et al. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol 1998; 153(2): 527-35.
37. Harada Y, et al. Activated hepatic stellate cells participate in liver fibrosis in a patient with transfusional iron overload. J Gastroenterol 1998; 33(5): 751-4.
38. Britton R S, Leicester K L, Bacon B R. Iron toxicity and chelation therapy. Int J Hematol 2002; 76(3): 219-28.
39. Marra F, et al. Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J Investig Med 1999; 47(1): 66-75.